InfuSystem Holdings, Inc. $INFU Shares Bought by North Star Investment Management Corp.

North Star Investment Management Corp. raised its holdings in InfuSystem Holdings, Inc. (NYSE:INFU) by 527.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 182,000 shares of the company’s stock after buying an additional 153,000 shares during the period. North Star Investment Management Corp.’s holdings in InfuSystem were worth $1,680,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Minerva Advisors LLC raised its stake in shares of InfuSystem by 5.2% in the fourth quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock valued at $9,676,000 after acquiring an additional 52,942 shares in the last quarter. Vanguard Group Inc. grew its stake in InfuSystem by 1.9% during the 3rd quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock worth $10,113,000 after purchasing an additional 18,539 shares in the last quarter. Punch & Associates Investment Management Inc. increased its holdings in InfuSystem by 1.9% during the 4th quarter. Punch & Associates Investment Management Inc. now owns 824,750 shares of the company’s stock worth $7,398,000 after purchasing an additional 15,000 shares during the period. Renaissance Technologies LLC increased its holdings in InfuSystem by 2.0% during the 4th quarter. Renaissance Technologies LLC now owns 587,509 shares of the company’s stock worth $5,270,000 after purchasing an additional 11,795 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in InfuSystem by 0.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company’s stock valued at $5,898,000 after purchasing an additional 4,430 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Price Performance

INFU stock opened at $9.88 on Tuesday. The business’s 50-day moving average is $9.41 and its two-hundred day moving average is $9.08. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The firm has a market capitalization of $199.40 million, a P/E ratio of 164.69 and a beta of 1.43. InfuSystem Holdings, Inc. has a 1 year low of $5.38 and a 1 year high of $11.04.

InfuSystem announced that its board has initiated a stock buyback program on Tuesday, May 19th that permits the company to buyback $20.00 million in shares. This buyback authorization permits the company to repurchase up to 10.2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling

In other news, Director Paul Andrew Gendron bought 5,000 shares of InfuSystem stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average price of $8.88 per share, with a total value of $44,400.00. Following the completion of the acquisition, the director directly owned 70,000 shares in the company, valued at $621,600. The trade was a 7.69% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Barry G. Steele bought 7,000 shares of InfuSystem stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.71 per share, for a total transaction of $60,970.00. Following the acquisition, the chief financial officer owned 96,590 shares of the company’s stock, valued at $841,298.90. This represents a 7.81% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 15,000 shares of company stock worth $131,490 over the last 90 days. Insiders own 10.80% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.